Showing results (51-60 of 229) with videos related to

Sort By:
Pageof 23
Diabetologia|March 1, 1997
Rat amylin mediates a pressor response in the anaesthetised rat: implications for the association between hypertension and diabetes mellitusJ M Haynes, W C Hodgson, M E Cooper
American Journal of Hypertension|January 1, 1995
Comparison of effects of ACE inhibition with calcium channel blockade on renal disease in a model combining genetic hypertension and diabetesJ R Rumble, A E Doyle, M E Cooper
The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association|March 6, 1999
Medical genetics on the cleft palate-craniofacial team: understanding parental preferenceN W Berk, M L Marazita, M E Cooper
Cardiovascular Drug Reviews|April 21, 2001
Angiotensin receptor blockers and the kidney: possible advantages over ACE inhibition?M E Cooper, R L Webb, M de Gasparo
The Biochemical Journal|February 15, 1987
The insulin- and glucagon-stimulated 'dense-vesicle' high-affinity cyclic AMP phosphodiesterase from rat liver. Purification, characterization and inhibitor sensitivityN J Pyne, M E Cooper, M D Houslay
Clinical and Experimental Pharmacology & Physiology|May 1, 1992
Mesenteric vascular angiotensin-converting enzyme is increased in experimental diabetes mellitusK Jandeleit, J Rumble, B Jackson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 29, 2000
Aminoguanidine ameliorates changes in the IGF system in experimental diabetic nephropathyL A Bach, R Dean, S Youssef, et al.
American Journal of Hypertension|May 23, 2001
Mechanisms of diabetic vasculopathy: an overviewM E Cooper, F Bonnet, M Oldfield, et al.
Kidney International|April 1, 1992
Angiotensin converting enzyme inhibition and calcium channel blockade in incipient diabetic nephropathy. The Melbourne Diabetic Nephropathy Study GroupG Jerums, T J Allen, C Tsalamandris, et al.
Diabetologia|April 1, 1995
The relative roles of advanced glycation, oxidation and aldose reductase inhibition in the development of experimental diabetic nephropathy in the Sprague-Dawley ratT Soulis-Liparota, M E Cooper, M Dunlop, et al.
Pageof 23